WALTHAM, Mass.--(BUSINESS WIRE)--SeQure Dx, a gene-editing diagnostics company, announced today a $17.5 million Series A funding led by RiverVest Venture Partners and Mass General Brigham Ventures ...
Oracle Corporation (NYSE:ORCL), along with seQure, a cybersecurity firm and its partner, disclosed the availability of seQure’s Ground-Truth service on Oracle Cloud Infrastructure (OCI). The company ...
PLANO, Texas, Jan. 14, 2025 /PRNewswire/ -- Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology ...
LONGMONT, Colo. & WALTHAM, Mass.--(BUSINESS WIRE)--KromaTiD and SeQure Dx announced today a partnership to market a comprehensive and integrated analysis of off-target gene editing in support of cell ...
Over the past few years a new class of soldering iron has arisen: a temperature controlled iron no longer tied to a bulky mains-powered base station, but using low-voltage DC power and with all ...
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a cell-engineering focused company announced the acquisition of SeQure Dx. This strategic acquisition strengthens MaxCyte’s ability to serve ex vivo and in ...
MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results